ARCHIVES

Zometa Can Reduce Risk Of Skeletal-Related Events

This article is from The Cancer Letter archive.

Vol. 34 No. 8 | August 26, 2011

Download PDF Visit The Full Archive

Related Articles

Evidence “Weak” Linking EMFs, cancer

June 25, 1999

Higgins: VA Groups D Have Review; NCI: It’s Ad Hoc

December 2, 1977

Phase III Trial Shows Benefit For Old Drugs, Old Device, For Ovarian Cancer, But Will Practice Change?

January 20, 2006

Weak Structure, Deficiencies, Cited In Dana-Farber Reviews

November 3, 1995

In Brief: Schmidt Has Doubts About Community Saturation Program; Diane Fink Wins Gerard Lambert Award

July 25, 1975

Oral Combination Provides Alternative To IV Chemo For Multiple Myeloma

November 29, 2002